Clinical Trial

Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.

Study acronym: EV-SoPRANO
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A Multicenter, acute, randomized, double-blind, placebo-controlled, flexible-dose trial with the treatment of sertraline.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2020-01-06; most recent amendment 2024-10-30.
Status change: Not Yet Recruiting → Recruiting 2020-07-22
Trial Details
NCT Number NCT04221997
Lead Sponsor University of Cincinnati
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Anxiety Disorders
Enrollment 150 participants
Start Date 2019-11-01
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2024-11-01